Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Fri Dec 15 16:30:43 UTC 2023
by
admin
on
Fri Dec 15 16:30:43 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
6KIC4BB60G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
123599
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
510415
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
46590
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
46590
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CINRYZE (AUTHORIZED: ANGIOEDEMAS, HEREDITARY)
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
67592
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
602117
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
WHO-ATC |
B06AC01
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
510415
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
95296
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
46490
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
NDF-RT |
N0000184172
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
NDF-RT |
N0000184172
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
185804
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
46490
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
95296
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/09/668
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
809864
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | RxNorm | ||
|
N0000010252
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | Decreased Vascular Permeability [PE] | ||
|
SUB130159
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
C87730
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
SUB39564
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
100000129592
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
DB06404
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
SUB39564
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
6KIC4BB60G
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
1018837-94-9
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
6KIC4BB60G
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | |||
|
N0000184151
Created by
admin on Fri Dec 15 16:30:43 UTC 2023 , Edited by admin on Fri Dec 15 16:30:43 UTC 2023
|
PRIMARY | Kallikrein Inhibitors [MoA] |
From | To |
---|---|
1_101 | 1_406 |
1_108 | 1_183 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_3 |
N | 1_47 |
N | 1_59 |
N | 1_216 |
N | 1_231 |
N | 1_250 |
N | 1_330 |
O | 1_26 |
O | 1_49 |
O | 1_61 |
O | 1_66 |
O | 1_70 |
O | 1_74 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
||
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT | CHEMICAL |
|